Confluence Pharmaceuticals LLC — Form D
Confluence Pharmaceuticals LLC of CARMEL, IN, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-07. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-11-07
- Form: D
- Accession: 0001689048-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $1.3M
- Amount sold: $1.3M
- Remaining: $15K
- Minimum investment: $25K
- Investors: 10
- Date of first sale: 2016-04-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-273918
Issuer
- Name: Confluence Pharmaceuticals LLC
- CIK: 0001689048
- Entity type: Limited Liability Company
- Jurisdiction: INDIANA
- Address: 4904 DEER RIDGE DRIVE SOUTH, CARMEL, IN, 46033
- Phone: (317) 379-7498
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Phil W Lodato | Director | Indianapolis, IN |
| Steven L Johns | Director | Carmel, IN |
| Steven L Johns | Executive Officer | Carmel, IN |
| Boyd W Sturdevant, Jr. | Director | Unionville, IN |
Other filings by this issuer (1)
More